Gene therapy to treat sickle cell disease and beta thalassemia greenlighted
Less than a month after the U.K. drug regulator approved Casgevy, the gene therapy to treat people above 12 with
Read MoreLess than a month after the U.K. drug regulator approved Casgevy, the gene therapy to treat people above 12 with
Read MoreEight years after the U.K. became the first country in the world to approve a reproductive technique known as mitochondrial
Read More